MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1039.94%
Quick Ratio
1026.39%
Cash Ratio
95.99%
Debt to Asset Ratio
9.56%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
24,772 25,179 25,399 37,608
Marketable securities
233,613 267,168 176,773 171,911
Restricted cash
NaN NaN NaN 114
Accounts receivable, net
343 329 NaN NaN
Restricted cash
NaN 0 0 100
Inventory
3,498 2,936 949 NaN
Prepaid expenses and other current assets
6,141 5,800 3,876 3,969
Total current assets
268,367 301,412 206,997 213,602
Property and equipment, net
1,096 1,189 1,258 1,169
Operating lease right-of-use asset
619 734 847 959
Other assets
2,453 2,541 1,602 1,602
Total assets
272,535 305,876 210,704 217,332
Accounts payable
10,929 4,167 4,323 2,854
Accrued liabilities
14,877 17,020 11,993 7,544
Total current liabilities
25,806 21,187 16,316 10,398
Operating lease liability, net
237 350 461 569
Total liabilities
26,043 21,537 16,777 10,967
Common stock, par value of 0.00001 per share 300,000,000 shares authorized 31,354,394 and 31,344,782 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
1 1 1 1
Additional paid-in capital
515,570 511,237 384,944 380,871
Accumulated deficit
-268,629 -227,141 -191,245 -174,545
Accumulated other comprehensive (loss) income
-450 242 227 38
Total stockholders equity
246,492 284,339 193,927 206,365
Total liabilities and stockholders equity
272,535 305,876 210,704 217,332
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$233,613K Cash and cashequivalents$24,772K Prepaid expenses andother current assets$6,141K Inventory$3,498K Accounts receivable, net$343K Total current assets$268,367K Other assets$2,453K Property and equipment,net$1,096K Operating leaseright-of-use asset$619K Total assets$272,535K Total liabilities andstockholders equity$272,535K Total stockholdersequity$246,492K Total liabilities$26,043K Accumulated deficit-$268,629K Accumulated othercomprehensive (loss) income-$450K Additional paid-in capital$515,570K Total currentliabilities$25,806K Operating leaseliability, net$237K Common stock, par valueof 0.00001 per...$1K Accrued liabilities$14,877K Accounts payable$10,929K

LENZ Therapeutics, Inc. (LENZ)

LENZ Therapeutics, Inc. (LENZ)